Mark For: KYZATREX™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88826033 |
Mark Literal Elements | KYZATREX |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMEG LAW OFFICE 101 2020-07-30 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Docket Number | KYZATREX |
2020-03-09 | Application Filed |
2020-03-12 | Location: NEW APPLICATION PROCESSING |
2020-03-12 | Status: Live/Pending |
2020-03-12 | Transaction Date |
2020-07-30 | Location: TMEG LAW OFFICE 101 |
2020-07-30 | Status: Applicant's response to a non-final Office action has been entered. The application is being returned to the examining attorney |
Party: | Marius Pharmaceuticals LLC |
Address | 8601 Six Forks Road 8601 Six Forks Road, Suite 630 Raleigh, NORTH CAROLINA UNITED STATES 27609 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DELAWARE |
Application | MULTI | 2020-03-09 |
Drawing | JPEG | 2020-03-09 |
Offc Action Outgoing | XML | 2020-06-04 |
XSearch Search Summary | XML | 2020-06-04 |
Change Address or Representation Form | MULTI | 2020-06-23 |
Response to Office Action | XML | 2020-07-10 |
Amendment and Mail Process Complete | MULTI | 2020-07-31 |
Notation to File | XML | 2020-08-03 |
XSearch Search Summary | XML | 2020-08-03 |
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely, testosterone and testosterone pro-drugs for the treatment of sub optimal levels of testosterone, primary and secondary hypogonadism, gynecological disorders, inflammatory diseases, cardiovascular disorders, frailty, and symptoms of COVID-19
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceutical preparations including testosterone and/or testosterone pro-drugs |
GS0051 | Pharmaceutical preparations, namely, testosterone pro-drugs for the treatment of sub optimal levels of testosterone, primary and secondary hypogonadism, and gynecological disorders |
Description | Date | Proceeding Number |
---|---|---|
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-07-30 | 66121 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-07-30 | 66121 |
ASSIGNED TO LIE | 2020-07-24 | 66121 |
ASSIGNED TO EXAMINER | 2020-07-23 | 76840 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-07-10 | |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-06-23 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-06-23 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-06-23 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-06-23 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-06-23 | 88888 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-04 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-06-04 | 77073 |
NON-FINAL ACTION E-MAILED | 2020-06-04 | 6325 |
ASSIGNED TO EXAMINER | 2020-05-29 | 77073 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-13 | |
NEW APPLICATION ENTERED IN TRAM | 2020-03-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.